Literature DB >> 14702214

Rod and cone signaling transmission in the retina of zebrafish: an erg study.

Jason Q Ren1, Lei Li.   

Abstract

It has been suggested that in lower vertebrates, visual signals are propagated in the retina using mixed bipolar cell pathways. In this article, we examined rod and cone signaling transmission in the retina of teleost zebrafish. Full-field electroretinograms (ERGs) were recorded from the cornea of control or 2-amino-4-phosphonobutyric acid (APB)-treated zebrafish. During dark adaptation following bright light adaptation, the intensity-response (V-log I) curve for both the ERG b- and d-waves shifted. In control animals, the b-wave response displayed a typical visual Purkinje shift and became more sensitive. By contrast, the d-wave became less sensitive. In the early dark adaptation, cone-dominant signals were readily recorded in both b- and d-waves. In the late dark adaptation, rod signals became dominant. However, no obvious d-wave was recorded. Intraocular injections of APB selectively blocked the b-wave, but revealed the d-wave in both early and late dark adaptation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14702214     DOI: 10.1080/00207450490269480

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  Olfactoretinal centrifugal input modulates zebrafish retinal ganglion cell activity: a possible role for dopamine-mediated Ca2+ signalling pathways.

Authors:  Luoxiu Huang; Hans Maaswinkel; Lei Li
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

2.  Effects of ethanol on photoreceptors and visual function in developing zebrafish.

Authors:  Jonathan I Matsui; Ana L Egana; Todd R Sponholtz; Alan R Adolph; John E Dowling
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

3.  ON-OFF Interactions in the Retina: Role of Glycine and GABA.

Authors:  Elka Popova
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.